Skip to search.
 TSX Up 0.10% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
34.64 Down 0.70(1.98%) 11:54AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:35.34
Open:35.19
Bid:34.90 x 100
Ask:35.02 x 100
1y Target Est:41.50
Beta:1.76
Next Earnings Date: 6-May-14ACOR Earnings announcement
Day's Range:34.50 - 35.49
52wk Range:27.51 - 40.87
Volume:159,060
Avg Vol (3m):519,858
Market Cap:1.42B
P/E (ttm):88.82
EPS (ttm):0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
ACORDown 1.98%1.42B
BIIBDown 0.17%68.79B
TEVAUp 0.88%42.70B

Key Statistics

Forward P/E (1 yr):40.23
P/S (ttm):4.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.53
Quarterly EPS Est (Mar-14) :0.10
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback